38 Followers on Owler
OverviewCompetitorsFundingNews & Insights

ONL Therapeutics Funding History

Since ONL Therapeutics was founded in 2006, it has participated in 11 rounds of funding. In total ONL Therapeutics has raised $149.2M. ONL Therapeutics' last funding round was on Sep 2024 for a total of $65.0M.

ONL Therapeutics Funding Rounds

ONL Therapeutics Investors

Unlock 15 more investors →

INVESTOR

ROUND

FUNDING DATE

Johnson & Johnson Innovation
Series D, Series B
Sep 2024, Dec 2020
Bios Partners
Series D, Equity, Series C, Series B
Sep 2024, Feb 2024, Mar 2023, Dec 2020
Novartis Venture Fund
Series D
Sep 2024
Visionary Ventures
Series D, Series C
Sep 2024, Mar 2023
Alpine Visionary Ventures
Series C
Mar 2023

Total Investors: 18

ONL Therapeutics has 18 investors, including Johnson & Johnson Innovation, Bios Partners and Novartis Venture Fund. The latest investment occurred in Sep 2024.